Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841100 · ClinicalTrials.gov registry record · Phase 2
Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT00841100 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 21 participants.
The verdict
NCT00841100, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
The investigators will investigate the effect of blood phenylalanine on Kuvan responsiveness in the same patients with PKU when their blood phenylalanine concentrations are altered by diet. Lowering blood phenylalanine concentrations in Kuvan non-responsive patients with PKU will increase the frequency of Kuvan responsiveness.
Interventions
- OTHER Diet
- DRUG Kuvan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-07-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00841100
The ClinicalTrials.gov registry entry for NCT00841100 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diet is the first listed.
NCT00841100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00841100 about?
NCT00841100 is a clinical study titled "Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response". The investigators will investigate the effect of blood phenylalanine on Kuvan responsiveness in the same patients with PKU when their blood phenylalanine concentrations are altered by diet. Lowering blood phenylalanine concentrations in Kuvan non-responsive patients with PKU will increase the frequ...
What is the current status of trial NCT00841100?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2008-12. Estimated completion is 2011-07-19.
What interventions are being tested in trial NCT00841100?
The interventions under investigation include: Diet (OTHER), Kuvan (DRUG).
Who is sponsoring clinical trial NCT00841100?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.